D
Sell
5/14/2024Downgrade
Apogee Therapeutics, Inc. (APGE) was downgraded to D- from D on 5/14/2024 due to a large decline in the efficiency index, volatility index and valuation index. Net income declined 1.13% from -$31.74M to -$32.09M.
D
Sell
10/6/2023None
Apogee Therapeutics, Inc. (APGE) was downgraded to D from U on 10/06/2023.
